{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Staphylococcus+%28S.%29+Aureus+Infection&page=2", "query": { "condition": "Staphylococcus (S.) Aureus Infection", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Staphylococcus+%28S.%29+Aureus+Infection&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-11T09:06:36.677Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04775953", "title": "DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Staphylococcal Bacteraemia" ], "interventions": [ { "name": "Cefazolin", "type": "DRUG" }, { "name": "Dalbavancin", "type": "DRUG" }, { "name": "Daptomycin", "type": "DRUG" }, { "name": "Nafcillin", "type": "DRUG" }, { "name": "Oxacillin", "type": "DRUG" }, { "name": "Vancomycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 200, "start_date": "2021-04-22", "completion_date": "2023-12-01", "has_results": true, "last_update_posted_date": "2024-12-10", "last_synced_at": "2026-06-11T09:06:36.677Z", "location_count": 23, "location_summary": "Birmingham, Alabama • Sacramento, California • Torrance, California + 19 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Sacramento", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04775953" }, { "nct_id": "NCT00822276", "title": "The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Methicillin-Resistant Staphylococcus Aureus", "Atopic Dermatitis", "Eczema Herpeticum", "MRSA" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "1 Year", "maximum_age": "80 Years", "sex": "ALL", "summary": "1 Year to 80 Years" }, "enrollment_count": 65, "start_date": "2009-02", "completion_date": "2009-11", "has_results": false, "last_update_posted_date": "2014-04-04", "last_synced_at": "2026-06-11T09:06:36.677Z", "location_count": 2, "location_summary": "San Diego, California • Denver, Colorado", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00822276" }, { "nct_id": "NCT06378359", "title": "Effectiveness of Screening and Decolonization of S. Aureus to Prevent S. Aureus Surgical Site Infections in Surgery Outpatients", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Staphylococcus Aureus Colonization", "Surgical Site Infections", "Healthcare Associated Infections" ], "interventions": [ { "name": "Screening and decolonization for SA carriers with the 3 drug bundle", "type": "OTHER" }, { "name": "No screening for SA", "type": "OTHER" }, { "name": "no screening", "type": "OTHER" }, { "name": "Nasal povidone-iodine on surgery day plus 2 CHG pre-op showers without screening.", "type": "OTHER" }, { "name": "Nasal alcohol gel on surgery day plus 2 CHG pre-op showers without screening", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": "2024-01-29", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-01-14", "last_synced_at": "2026-06-11T09:06:36.677Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06378359" }, { "nct_id": "NCT03455309", "title": "Evaluation of NDV-3A Vaccine in Preventing S. Aureus Colonization", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Staphylococcus Aureus" ], "interventions": [ { "name": "NDV-3A", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "NovaDigm Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "17 Years", "maximum_age": "35 Years", "sex": "MALE", "summary": "17 Years to 35 Years · Male only" }, "enrollment_count": 382, "start_date": "2018-01-30", "completion_date": "2019-10-15", "has_results": false, "last_update_posted_date": "2020-01-29", "last_synced_at": "2026-06-11T09:06:36.677Z", "location_count": 1, "location_summary": "Fort Benning, Georgia", "locations": [ { "city": "Fort Benning", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03455309" }, { "nct_id": "NCT05763602", "title": "PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Surgical Site Infection" ], "interventions": [ { "name": "povidone-iodine topical ointment", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Loreen Herwaldt", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2000, "start_date": "2022-09-15", "completion_date": "2026-05-31", "has_results": false, "last_update_posted_date": "2026-02-04", "last_synced_at": "2026-06-11T09:06:36.677Z", "location_count": 6, "location_summary": "Atlanta, Georgia • Indianapolis, Indiana • Iowa City, Iowa + 3 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05763602" }, { "nct_id": "NCT03140423", "title": "Mupirocin-Iodophor ICU Decolonization Swap Out Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Staphylococcus Aureus" ], "interventions": [ { "name": "Arm 1. Routine Care (Mupirocin/CHG)", "type": "DRUG" }, { "name": "Arm 2. Iodophor/CHG Decolonization", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Harvard Pilgrim Health Care", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 353323, "start_date": "2017-05-01", "completion_date": "2023-11-06", "has_results": true, "last_update_posted_date": "2025-03-30", "last_synced_at": "2026-06-11T09:06:36.677Z", "location_count": 137, "location_summary": "Riverside, California • San Jose, California • Thousand Oaks, California + 103 more", "locations": [ { "city": "Riverside", "state": "California" }, { "city": "San Jose", "state": "California" }, { "city": "San Jose", "state": "California" }, { "city": "Thousand Oaks", "state": "California" }, { "city": "West Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03140423" }, { "nct_id": "NCT04160468", "title": "Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Staphylococcus Aureus Bacteremia", "Staphylococcus Aureus Endocarditis" ], "interventions": [ { "name": "Exebacase", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ContraFect", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 259, "start_date": "2019-12-20", "completion_date": "2022-09-09", "has_results": true, "last_update_posted_date": "2023-11-02", "last_synced_at": "2026-06-11T09:06:36.677Z", "location_count": 55, "location_summary": "Birmingham, Alabama • Orange, California • Sacramento, California + 47 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Orange", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Sylmar", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04160468" }, { "nct_id": "NCT01827358", "title": "Safety and Efficacy of Mupirocin in Eradicating Colonization With S. Aureus in Critically Ill Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Staphylococcal Infection" ], "interventions": [ { "name": "Mupirocin calcium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "24 Months", "sex": "ALL", "summary": "Up to 24 Months" }, "enrollment_count": 155, "start_date": "2014-04-30", "completion_date": "2016-06-21", "has_results": true, "last_update_posted_date": "2017-07-07", "last_synced_at": "2026-06-11T09:06:36.677Z", "location_count": 6, "location_summary": "Atlanta, Georgia • Baltimore, Maryland • Kansas City, Missouri + 3 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01827358" }, { "nct_id": "NCT00729937", "title": "Strategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus \"STOP MRSA\"", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Staphylococcal Infection" ], "interventions": [ { "name": "Cephalexin", "type": "DRUG" }, { "name": "Clindamycin", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Trimethoprim-sulfamethoxazole", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 2265, "start_date": "2009-04", "completion_date": "2013-06", "has_results": true, "last_update_posted_date": "2015-02-18", "last_synced_at": "2026-06-11T09:06:36.677Z", "location_count": 5, "location_summary": "Phoenix, Arizona • Sylmar, California • Baltimore, Maryland + 2 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Sylmar", "state": "California" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00729937" }, { "nct_id": "NCT04666532", "title": "S. Aureus Translocation From Skin and Nose to Periprosthetic Tissues", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Staphylococcus Aureus" ], "interventions": [], "intervention_types": [], "sponsor": "Rothman Institute Orthopaedics", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2020-10-22", "completion_date": "2021-12-31", "has_results": false, "last_update_posted_date": "2020-12-14", "last_synced_at": "2026-06-11T09:06:36.677Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04666532" } ] }